Loading...
Recent Advances in GLP-1 Receptor Agonists for Use in Diabetes Mellitus
Mimetics of Glucagon-like peptide 1 (GLP-1) are becoming a useful alternative or complementary treatment choice to insulin in the treatment of diabetes mellitus. The lack of hypoglycemia as a side effect when GLP-1 receptor agonists are used along with the tendency of these therapeutic agents to pre...
Na minha lista:
| Udgivet i: | Drug Dev Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5602594/ https://ncbi.nlm.nih.gov/pubmed/28786125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21404 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|